HIV in NYC: Statistics and Reports

HIV Surveillance Annual Reports:

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

HIV Surveillance Midyear and Quarterly Reports:

Midyear 2024 | Midyear 2019

Annual HIV Surveillance Statistics

2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001

These tables describe new diagnoses of HIV and AIDS, people with HIV and AIDS, and deaths among people with HIV and AIDS, for New York City overall, and by gender, race or ethnicity, age, borough, transmission category, and neighborhood.

• HIV in New York City, 2024 (PDF)
• HIV in the Bronx, 2024 (PDF)
• HIV in Brooklyn, 2024 (PDF)
• HIV in Manhattan, 2024 (PDF)
• HIV in Queens, 2024 (PDF)
• HIV in Staten Island, 2024 (PDF)
• HIV Among People with Perinatally Transmitted HIV, 2024 (PDF)
• HIV Among Men Who Have Sex with Men in New York City, 2024 (PDF)
• HIV Among People Born Outside of the U.S. in New York City, 2024 (PDF)
• HIV Among Transgender People in New York City, 2024 (PDF)
• HIV Among Women in New York City, 2024 (PDF)
• HIV Among People Aged 13 to 29 Years in New York City, 2024 (PDF)
• HIV Among People Aged 50 or More Years in New York City, 2024 (PDF)

Suggested Citation: HIV Epidemiology Program. New York City HIV Surveillance Slide Sets, 2024. New York City Department of Health and Mental Hygiene: New York, NY. December 2025. Accessed [access date] at HIV in NYC: Statistics and Reports.

Age:

Age is calculated as age at diagnosis for HIV and AIDS diagnoses; age at the end of the reporting period for people with HIV; and age at death for deaths.

AIDS diagnosis:

People receive an AIDS diagnosis when their CD4 cell count drops below 200 cells per milliliter of blood, or they are diagnosed with an opportunistic illness.

Concurrent HIV and AIDS diagnoses:

Concurrent HIV and AIDS diagnoses are when an AIDS diagnosis is made within 31 days of an HIV diagnosis. People concurrently diagnosed with HIV and AIDS are included in the totals of both HIV diagnoses and AIDS diagnoses.

Gender:

Gender categories include men, women, transgender men, transgender women, and additional gender identities. People whose current gender identity differs from their sex assigned at birth are considered transgender, and people who report nonbinary, genderqueer, gender-nonconforming, or any gender identity not previously listed are classified under the additional gender identities category. Gender identities are based on limited reported HIV surveillance data and are listed without any intended hierarchy or prioritization. Gender categories are mutually exclusive, with people classified under only one gender category. Classifying gender in surveillance requires accurate collection of sex assigned at birth and gender identity data. Data on people’s sex assigned at birth and gender identity are collected from their self-reports, their health care providers, or medical chart reviews. This information may or may not be complete or accurately reflects how a person self-identifies.

HIV diagnosis:

A diagnosis of HIV is generally based on a positive multi-test algorithm (screening immunoassay, HIV-1/2 differentiation assay, and RNA test) in adults and a positive PCR (polymerase chain reaction) test in infants younger than 18 months. Since June 1, 2000, laboratories and health care providers in New York State have been required to report positive HIV test results even in people without AIDS.

Race and ethnicity:

Black, white, Asian or Pacific Islander, Native American, and multiracial race categories exclude Latino ethnicity. People with Latino ethnicity are classified under the Latino race and ethnicity category, regardless of their race classification. People not identified as Latino who identify with more than one race are classified under multiracial. Data on people’s race and ethnicity are collected through their self-reports, their health care providers, medical chart review, or vital statistics records.

Transmission category:

Data on people’s behaviors possibly related to HIV transmission that occurred any time prior to diagnosis are collected through their self-reports, their health care providers, and medical chart review.

Transmission categories include men who have sex with men, injection drug use history, men who have sex with men and have an injection drug use history, heterosexual contact, transgender people with sexual contact, perinatal transmission, and other.

The men who have sex with men category includes men with reported sexual contact with another man, and men with a history of a rectal or anal sexually transmitted infection or proctitis and no other definitive transmission category.

The injection drug use history category includes people with a history of taking nonprescribed drugs by injection, intravenously, intramuscularly, or subcutaneously, excluding men also reporting a history of sex with men.

The men who have sex with men and have an injection drug use history category includes people meeting the definition of both the men who have sex with men category and the injection drug use history category as described above.

The heterosexual contact category includes people who had heterosexual sex with a person they know to have HIV, a person they know to have an injection drug use history, or a person they know to have received blood products; for women only, it also includes people with a history of sex work, multiple sex partners, sexually transmitted infection, crack or cocaine use, sex with a bisexual man, probable heterosexual transmission as noted in their medical chart, or sex with a man and no injection drug use history.

The transgender people with sexual contact category includes people identified as transgender at any time who reported sexual contact and no injection drug use history. Transgender people with injection drug use history are categorized under the injection drug use history category.

The perinatal category includes people who were exposed to HIV during gestation, during birth, or postpartum through breastfeeding.

The other category includes people who received treatment for hemophilia, people who received a transfusion or transplant, people with other health care-associated transmission, and children with nonperinatal transmission.

The unknown category includes people for whom the data needed to classify them under one of the above transmission categories was not available.

UHF neighborhood:

UHF neighborhood corresponds to a geographic area within New York City that is an aggregate of between one and nine ZIP codes but is smaller than a borough. UHF neighborhoods reflect catchment areas for certain health care facilities. See the table and map of UHF neighborhoods and corresponding ZIP codes (PDF).

New York State law requires providers to report new diagnoses of HIV, AIDS, and HIV-related illness, and laboratories to report patients’ positive HIV test results, viral loads, CD4 counts, and nucleotide sequences results. The NYC Department of Health and Mental Hygiene investigates provider and laboratory reports to identify transmission risk and dates of diagnosis, and searches for unreported diagnoses.

For more information, call 311 or email HIVreport@health.nyc.gov.

• Sexual and Substance Use Behaviors and HIV Prevalence Among Women of Transgender Experience and Transfeminine People (PDF)
• Sexual and Substance Use Behaviors Among Men Who Have Sex With Men in New York City (PDF, June 2025)
• HIV Risk Among People Who Inject Drugs in New York City from the 2022 National HIV Behavioral Surveillance Study (PDF, June 2024)
• National HIV Behavioral Surveillance Study among Transgender Women Factsheet 2019 (PDF, September 2020)
• HIV Risk and Prevalence among Heterosexually Active Adults at Increased Risk in NYC from the 2019 National HIV Behavioral Surveillance Study (PDF, July 2020)
• HIV Risk and Prevalence among People who Inject Drugs in New York City from the 2018 National HIV Behavioral Surveillance Study (PDF)
• HIV Risk and Prevalence among Men who Have Sex with Men in New York City: Results from the 2017 National HIV Behavioral Surveillance Study (PDF)
• HIV Risk and Prevalence among Heterosexuals at Increased Risk for HIV in New York City: Results from the National HIV Behavioral Surveillance Study among High-Risk Women, 2016 (PDF, January 2018)
• HIV Risk and Prevalence among New York City Injection Drug Users: 2015 National HIV Behavioral Surveillance Study (PDF, January 2018)

Project EXPAND aims to expand data collection to assess social determinants of health and missed opportunities for HIV prevention among those newly diagnosed with HIV from heavily-affected communities.

• Expanded HIV Surveillance Among Persons Newly Diagnosed with HIV in New York City, “Project EXPAND,” 2024 Findings (PDF)